首页> 外文OA文献 >Safety and Resource Utilization by Non-small Cell Lung Cancer Histology: Results from the Randomized Phase III Study of Pemetrexed Plus Cisplatin versus Gemcitabine Plus Cisplatin in Chemonaïve Patients with Advanced Non-small Cell Lung Cancer

【2h】

Safety and Resource Utilization by Non-small Cell Lung Cancer Histology: Results from the Randomized Phase III Study of Pemetrexed Plus Cisplatin versus Gemcitabine Plus Cisplatin in Chemonaïve Patients with Advanced Non-small Cell Lung Cancer

机译：非小细胞肺癌组织学的安全性和资源利用：培美曲塞加顺铂与吉西他滨加顺铂在晚期放化疗患者中的随机化III期研究结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Novello Silvia; Pimentel Francisco Luis; Douillard Jean-Yves; OBrien Mary; von Pawel Joachim; Eckardt John; Liepa Astra M.; Simms Lorinda; Visseren-Grul Carla; Paz-Ares Luis;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Safety and resource utilization by non-small cell lung cancer histology: results from the randomized phase III study of pemetrexed plus cisplatin versus gemcitabine plus cisplatin in chemonaive patients with advanced non-small cell lung cancer. [J] . Novello S, Pimentel FL, Douillard JY, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2010,第10期

机译：非小细胞肺癌组织学的安全性和资源利用：培美曲塞加顺铂与吉西他滨加顺铂在晚期非小细胞肺癌化疗放化疗患者中进行的随机III期研究结果。
2. Efficacy and safety of cisplatin/pemetrexed versus cisplatin/gemcitabine as first-line treatment in East Asian patients with advanced non-small cell lung cancer: results of an exploratory subgroup analysis of a phase III trial. [J] . Yang CH, Simms L, Park K, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2010,第5期

机译：顺铂/培美曲塞与顺铂/吉西他滨作为一线治疗在东亚晚期非小细胞肺癌患者中的疗效和安全性：III期临床试验亚组分析的结果。
3. Survival without toxicity for cisplatin plus pemetrexed versus cisplatin plus gemcitabine in chemonaive patients with advanced non-small cell lung cancer: a risk-benefit analysis of a large phase III study. [J] . Scagliotti GV, Park K, Patil S, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2009,第13期

机译：顺铂加培美曲塞与顺铂加吉西他滨无毒生存在晚期非小细胞肺癌放化疗患者中的风险：一项大型III期研究的风险获益分析。
4. Pemetrexed versus docetaxel single agent chemotherapy in chemotherapy-naive elderly patients with advanced non-small cell lung cancer [C] . Hua Xin, Zhenguo Han, Haibo Huang 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：培美曲塞与多西他赛单药化疗在未接受化疗的老年晚期非小细胞肺癌患者中的作用
5. Assessing the effectiveness of palliative chemotherapy for non-small cell lung cancer: A phase IV study of patients treated at Ontario's cancer centres [D] . Harrison, Lyndsay Dawn. 2012

机译：评估姑息化疗对非小细胞肺癌的有效性：在安大略省癌症中心接受治疗的患者的IV期研究
6. Efficacy and Safety of First-Line Necitumumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in East Asian Patients with Stage IV Squamous Non-small Cell Lung Cancer: A Subgroup Analysis of the Phase 3 Open-Label Randomized SQUIRE Study [O] . Keunchil Park, Eun Kyung Cho, Maximino Bello, 2017

机译：一线尼西妥单抗联合吉西他滨和顺铂与吉西他滨和顺铂对东亚IV期鳞状非小细胞肺癌患者的疗效和安全性：3期开放标签随机SQUIRE研究的亚组分析
7. Efficacy and Safety of Cisplatin/Pemetrexed Versus Cisplatin/Gemcitabine as First-Line Treatment in East Asian Patients with Advanced Non-small Cell Lung Cancer: Results of an Exploratory Subgroup Analysis of a Phase III Trial [O] . Chih-Hsin Yang, Lorinda Simms, Keunchil Park, 2010

机译：顺铂/聚氯胺蛋白/芽蛋白/吉西他滨的疗效和安全性是东亚患者先进的非小细胞肺癌的一线治疗：III期试验的探索性亚组分析的结果

Safety and Resource Utilization by Non-small Cell Lung Cancer Histology: Results from the Randomized Phase III Study of Pemetrexed Plus Cisplatin versus Gemcitabine Plus Cisplatin in Chemonaïve Patients with Advanced Non-small Cell Lung Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅